Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 83 of 98, showing 5 Applications out of 488 total, starting on record 411, ending on 415

# Protocol No Study Title Investigator(s) & Site(s)

411.

ECCT/14/09/01   Extension to study MALARIA-055 PRI (110021) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’candidate malaria vaccine (SB257049) in infants and children in Africa
    An open extension to the phase III, multi-center study MALARIA-055 PRI (110021) to evaluate long-term efficacy, safety and immunogenicity of the RTS,S/AS01E candidate vaccine against malaria disease caused by Plasmodium falciparum in infants and children in Africa.   Study number: MALARIA-076 (200599)   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project
 
View

412.

ECCT/14/08/02   A5288
    Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)   
Principal Investigator(s)
1. ESTHER MUMBI MAKANGA
Site(s) in Kenya
KEMRI/CDC CLINICAL RESEARCH CENTRE
 
View

413.

ECCT/14/08/03   STAND Study (Shortening Treatment by Advancing Novel Drugs)
    Long Title:   A Phase 3 Open Label Partially Randomised Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA-824 plus Pyrazinamide after 4 and 6 months of Treatment in Adult Subjects with Drug Sensitive Smear Positive Pulmonary Tuberculosis and after 6 months of Treatment in Adult Subjects with Multi-Drug Resistant, Smear-Positive Pulmonary Tuberculosis       Short Title:   STAND Study (Shortening Treatment by Advancing Novel Drugs)   
Principal Investigator(s)
1. Dr Videlis Nduba
2. Dr Evans Amukoye
Site(s) in Kenya
1. KEMRI-CRDR(East Nairobi) (Nairobi City county)
2. KEMRI-CRDR(West Nairobi) (Nairobi City county)
 
View

414.

ECCT/14/08/05   Brief Bactericidal Activity of Anti TB drugs
    Brief Bactericidal Activity of Anti-Tuberculosis Drugs   
Principal Investigator(s)
1. Videlis Nzioka Nduba
Site(s) in Kenya
KEMRI-CGHR
 
View

415.

ECCT/14/10/01  
    Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya   
Principal Investigator(s)
1. Rebeca Milanesi Plank
2. Robert Bailey
Site(s) in Kenya
Nyanza Reproductive Health Society
 
View